+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Mesenchymal Stem Cells Market Intelligence Report - Global Forecast to 2027

  • PDF Icon

    Report

  • 124 Pages
  • July 2022
  • Region: Global
  • Think Market Intelligence
  • ID: 5623904
UP TO OFF until Dec 31st 2022
The Global Mesenchymal Stem Cells Market is projected to reach USD 5,847.88 million by 2027 from USD 2,731.51 million in 2021, at a CAGR of 13.52% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas Mesenchymal Stem Cells Market size was estimated at USD 1,113.77 million in 2021 and expected to reach USD 1,244.58 million in 2022, at a CAGR of 12.99% to reach USD 2,317.98 million by 2027.
  • The Asia-Pacific Mesenchymal Stem Cells Market size was estimated at USD 667.85 million in 2021 and expected to reach USD 780.85 million in 2022, at a CAGR of 14.67% to reach USD 1,518.45 million by 2027.
  • The Europe, Middle East & Africa Mesenchymal Stem Cells Market size was estimated at USD 949.88 million in 2021 and expected to reach USD 1,070.73 million in 2022, at a CAGR of 13.31% to reach USD 2,011.44 million by 2027.

Market Segmentation & Coverage:

The report on mesenchymal stem cells identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the mesenchymal stem cells to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

  • Allogeneic
  • Autologous

Indication:

  • Bone & Cartilage Repair
  • Cancer
  • Cardiovascular Disease
  • GvHD
  • Inflammatory & Immunological Disease
  • Liver Diseases

Source of Isolation:

  • Adipose Tissues
  • Bone Marrow
  • Cord Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Peripheral Blood

Application:

  • Disease Modeling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa
    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Astellas Pharma Inc.
  • Axol Biosciences Ltd.
  • BrainStorm Cell Therapeutics Inc.
  • Cell Applications, Inc.
  • Celprogen, Inc.
  • Cyagen Biosciences, Inc.
  • Genlantis, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Mesoblast Limited
  • Neuromics
  • Pluristem Therapeutics Inc.
  • PromoCell GmbH
  • R&D Systems, Inc.
  • ScienCell Research Laboratories, Inc.
  • Smith & Nephew PLC
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation
Frequently Asked Questions about the Global Mesenchymal Stem Cells Market

What is the estimated value of the Global Mesenchymal Stem Cells Market?

The Global Mesenchymal Stem Cells Market was estimated to be valued at $2731.51 Million in 2021.

What is the growth rate of the Global Mesenchymal Stem Cells Market?

The growth rate of the Global Mesenchymal Stem Cells Market is 13.5%, with an estimated value of $5847.88 Million by 2027.

What is the forecasted size of the Global Mesenchymal Stem Cells Market?

The Global Mesenchymal Stem Cells Market is estimated to be worth $5847.88 Million by 2027.

Who are the key companies in the Global Mesenchymal Stem Cells Market?

Key companies in the Global Mesenchymal Stem Cells Market include Astellas Pharma Inc., Axol Biosciences Ltd., BrainStorm Cell Therapeutics Inc., Cell Applications, Inc., Celprogen, Inc., Cyagen Biosciences, Inc., Genlantis, Inc., Lonza Group AG and Mesoblast Limited.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Market Overview
4. Mesenchymal Stem Cells Market, by Type
4.1. Introduction
4.2. Allogeneic
4.3. Autologous
5. Mesenchymal Stem Cells Market, by Indication
5.1. Introduction
5.2. Bone & Cartilage Repair
5.3. Cancer
5.4. Cardiovascular Disease
5.5. GvHD
5.6. Inflammatory & Immunological Disease
5.7. Liver Diseases
6. Mesenchymal Stem Cells Market, by Source of Isolation
6.1. Introduction
6.2. Adipose Tissues
6.3. Bone Marrow
6.4. Cord Blood
6.5. Fallopian Tube
6.6. Fetal Liver
6.7. Lung
6.8. Peripheral Blood
7. Mesenchymal Stem Cells Market, by Application
7.1. Introduction
7.2. Disease Modeling
7.3. Drug Development & Discovery
7.4. Stem Cell Banking
7.5. Tissue Engineering
7.6. Toxicology Studies
8. Company Usability Profiles
8.1. Astellas Pharma Inc.
8.2. Axol Biosciences Ltd.
8.3. BrainStorm Cell Therapeutics Inc.
8.4. Cell Applications, Inc.
8.5. Celprogen, Inc.
8.6. Cyagen Biosciences, Inc.
8.7. Genlantis, Inc.
8.8. Lonza Group AG
8.9. Merck KGaA
8.10. Mesoblast Limited
8.11. Neuromics
8.12. Pluristem Therapeutics Inc.
8.13. PromoCell GmbH
8.14. R&D Systems, Inc.
8.15. ScienCell Research Laboratories, Inc.
8.16. Smith & Nephew PLC
8.17. Stemcell Technologies Inc.
8.18. Stemedica Cell Technologies, Inc.
8.19. Thermo Fisher Scientific, Inc.
8.20. Vericel Corporation
9. Appendix
9.1. Discussion Guide
9.2. License & Pricing
List of Figures
Figure 1. Global Mesenchymal Stem Cells Market: Research Process
Figure 2. Global Mesenchymal Stem Cells Market Size, 2019-2027 (USD Million)
Figure 3. Global Mesenchymal Stem Cells Market Size, by Region, 2021 Vs 2027 (%)
Figure 4. Global Mesenchymal Stem Cells Market Size, by Region, 2021 Vs 2027 (USD Million)
Figure 5. Global Mesenchymal Stem Cells Market Competitive Strategic Window, by Region, 2027
Figure 6. Global Mesenchymal Stem Cells Market Size, by Country, 2021 Vs 2027 (%)
Figure 7. Global Mesenchymal Stem Cells Market Size, by Country, 2021 Vs 2027 (USD Million)
Figure 8. Global Mesenchymal Stem Cells Market Competitive Strategic Window, by Country, 2027
Figure 9. Global Mesenchymal Stem Cells Market Size, by Type, 2021 Vs 2027 (%)
Figure 10. Global Mesenchymal Stem Cells Market Size, by Type, 2021 Vs 2027 (USD Million)
Figure 11. Global Mesenchymal Stem Cells Market Competitive Strategic Window, by Type, 2027
Figure 12. Global Mesenchymal Stem Cells Market Size, by Allogeneic, 2019-2027 (USD Million)
Figure 13. Global Mesenchymal Stem Cells Market Size, by Autologous, 2019-2027 (USD Million)
Figure 14. Global Mesenchymal Stem Cells Market Size, by Indication, 2021 Vs 2027 (%)
Figure 15. Global Mesenchymal Stem Cells Market Size, by Indication, 2021 Vs 2027 (USD Million)
Figure 16. Global Mesenchymal Stem Cells Market Competitive Strategic Window, by Indication, 2027
Figure 17. Global Mesenchymal Stem Cells Market Size, by Bone & Cartilage Repair, 2019-2027 (USD Million)
Figure 18. Global Mesenchymal Stem Cells Market Size, by Cancer, 2019-2027 (USD Million)
Figure 19. Global Mesenchymal Stem Cells Market Size, by Cardiovascular Disease, 2019-2027 (USD Million)
Figure 20. Global Mesenchymal Stem Cells Market Size, by Gvhd, 2019-2027 (USD Million)
Figure 21. Global Mesenchymal Stem Cells Market Size, by Inflammatory & Immunological Disease, 2019-2027 (USD Million)
Figure 22. Global Mesenchymal Stem Cells Market Size, by Liver Diseases, 2019-2027 (USD Million)
Figure 23. Global Mesenchymal Stem Cells Market Size, by Source Of Isolation, 2021 Vs 2027 (%)
Figure 24. Global Mesenchymal Stem Cells Market Size, by Source Of Isolation, 2021 Vs 2027 (USD Million)
Figure 25. Global Mesenchymal Stem Cells Market Competitive Strategic Window, by Source Of Isolation, 2027
Figure 26. Global Mesenchymal Stem Cells Market Size, by Adipose Tissues, 2019-2027 (USD Million)
Figure 27. Global Mesenchymal Stem Cells Market Size, by Bone Marrow, 2019-2027 (USD Million)
Figure 28. Global Mesenchymal Stem Cells Market Size, by Cord Blood, 2019-2027 (USD Million)
Figure 29. Global Mesenchymal Stem Cells Market Size, by Fallopian Tube, 2019-2027 (USD Million)
Figure 30. Global Mesenchymal Stem Cells Market Size, by Fetal Liver, 2019-2027 (USD Million)
Figure 31. Global Mesenchymal Stem Cells Market Size, by Lung, 2019-2027 (USD Million)
Figure 32. Global Mesenchymal Stem Cells Market Size, by Peripheral Blood, 2019-2027 (USD Million)
Figure 33. Global Mesenchymal Stem Cells Market Size, by Application, 2021 Vs 2027 (%)
Figure 34. Global Mesenchymal Stem Cells Market Size, by Application, 2021 Vs 2027 (USD Million)
Figure 35. Global Mesenchymal Stem Cells Market Competitive Strategic Window, by Application, 2027
Figure 36. Global Mesenchymal Stem Cells Market Size, by Disease Modeling, 2019-2027 (USD Million)
Figure 37. Global Mesenchymal Stem Cells Market Size, by Drug Development & Discovery, 2019-2027 (USD Million)
Figure 38. Global Mesenchymal Stem Cells Market Size, by Stem Cell Banking, 2019-2027 (USD Million)
Figure 39. Global Mesenchymal Stem Cells Market Size, by Tissue Engineering, 2019-2027 (USD Million)
Figure 40. Global Mesenchymal Stem Cells Market Size, by Toxicology Studies, 2019-2027 (USD Million)
List of Tables
Table 1. Global Mesenchymal Stem Cells Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2019-2021
Table 3. Global Mesenchymal Stem Cells Market Size, 2019-2027 (USD Million)
Table 4. Global Mesenchymal Stem Cells Market Size, by Region, 2019-2027 (USD Million)
Table 5. Global Mesenchymal Stem Cells Market Size, by Country, 2019-2027 (USD Million)
Table 6. Global Mesenchymal Stem Cells Market Size, by Type, 2019-2027 (USD Million)
Table 7. Global Mesenchymal Stem Cells Market Size, by Allogeneic, 2019-2027 (USD Million)
Table 8. Global Mesenchymal Stem Cells Market Size, by Allogeneic, by Region, 2019-2027 (USD Million)
Table 9. Global Mesenchymal Stem Cells Market Size, by Allogeneic, by Region, 2019-2027 (USD Million)
Table 10. Global Mesenchymal Stem Cells Market Size, by Autologous, 2019-2027 (USD Million)
Table 11. Global Mesenchymal Stem Cells Market Size, by Autologous, by Region, 2019-2027 (USD Million)
Table 12. Global Mesenchymal Stem Cells Market Size, by Autologous, by Region, 2019-2027 (USD Million)
Table 13. Global Mesenchymal Stem Cells Market Size, by Indication, 2019-2027 (USD Million)
Table 14. Global Mesenchymal Stem Cells Market Size, by Bone & Cartilage Repair, 2019-2027 (USD Million)
Table 15. Global Mesenchymal Stem Cells Market Size, by Bone & Cartilage Repair, by Region, 2019-2027 (USD Million)
Table 16. Global Mesenchymal Stem Cells Market Size, by Bone & Cartilage Repair, by Region, 2019-2027 (USD Million)
Table 17. Global Mesenchymal Stem Cells Market Size, by Cancer, 2019-2027 (USD Million)
Table 18. Global Mesenchymal Stem Cells Market Size, by Cancer, by Region, 2019-2027 (USD Million)
Table 19. Global Mesenchymal Stem Cells Market Size, by Cancer, by Region, 2019-2027 (USD Million)
Table 20. Global Mesenchymal Stem Cells Market Size, by Cardiovascular Disease, 2019-2027 (USD Million)
Table 21. Global Mesenchymal Stem Cells Market Size, by Cardiovascular Disease, by Region, 2019-2027 (USD Million)
Table 22. Global Mesenchymal Stem Cells Market Size, by Cardiovascular Disease, by Region, 2019-2027 (USD Million)
Table 23. Global Mesenchymal Stem Cells Market Size, by Gvhd, 2019-2027 (USD Million)
Table 24. Global Mesenchymal Stem Cells Market Size, by Gvhd, by Region, 2019-2027 (USD Million)
Table 25. Global Mesenchymal Stem Cells Market Size, by Gvhd, by Region, 2019-2027 (USD Million)
Table 26. Global Mesenchymal Stem Cells Market Size, by Inflammatory & Immunological Disease, 2019-2027 (USD Million)
Table 27. Global Mesenchymal Stem Cells Market Size, by Inflammatory & Immunological Disease, by Region, 2019-2027 (USD Million)
Table 28. Global Mesenchymal Stem Cells Market Size, by Inflammatory & Immunological Disease, by Region, 2019-2027 (USD Million)
Table 29. Global Mesenchymal Stem Cells Market Size, by Liver Diseases, 2019-2027 (USD Million)
Table 30. Global Mesenchymal Stem Cells Market Size, by Liver Diseases, by Region, 2019-2027 (USD Million)
Table 31. Global Mesenchymal Stem Cells Market Size, by Liver Diseases, by Region, 2019-2027 (USD Million)
Table 32. Global Mesenchymal Stem Cells Market Size, by Source Of Isolation, 2019-2027 (USD Million)
Table 33. Global Mesenchymal Stem Cells Market Size, by Adipose Tissues, 2019-2027 (USD Million)
Table 34. Global Mesenchymal Stem Cells Market Size, by Adipose Tissues, by Region, 2019-2027 (USD Million)
Table 35. Global Mesenchymal Stem Cells Market Size, by Adipose Tissues, by Region, 2019-2027 (USD Million)
Table 36. Global Mesenchymal Stem Cells Market Size, by Bone Marrow, 2019-2027 (USD Million)
Table 37. Global Mesenchymal Stem Cells Market Size, by Bone Marrow, by Region, 2019-2027 (USD Million)
Table 38. Global Mesenchymal Stem Cells Market Size, by Bone Marrow, by Region, 2019-2027 (USD Million)
Table 39. Global Mesenchymal Stem Cells Market Size, by Cord Blood, 2019-2027 (USD Million)
Table 40. Global Mesenchymal Stem Cells Market Size, by Cord Blood, by Region, 2019-2027 (USD Million)
Table 41. Global Mesenchymal Stem Cells Market Size, by Cord Blood, by Region, 2019-2027 (USD Million)
Table 42. Global Mesenchymal Stem Cells Market Size, by Fallopian Tube, 2019-2027 (USD Million)
Table 43. Global Mesenchymal Stem Cells Market Size, by Fallopian Tube, by Region, 2019-2027 (USD Million)
Table 44. Global Mesenchymal Stem Cells Market Size, by Fallopian Tube, by Region, 2019-2027 (USD Million)
Table 45. Global Mesenchymal Stem Cells Market Size, by Fetal Liver, 2019-2027 (USD Million)
Table 46. Global Mesenchymal Stem Cells Market Size, by Fetal Liver, by Region, 2019-2027 (USD Million)
Table 47. Global Mesenchymal Stem Cells Market Size, by Fetal Liver, by Region, 2019-2027 (USD Million)
Table 48. Global Mesenchymal Stem Cells Market Size, by Lung, 2019-2027 (USD Million)
Table 49. Global Mesenchymal Stem Cells Market Size, by Lung, by Region, 2019-2027 (USD Million)
Table 50. Global Mesenchymal Stem Cells Market Size, by Lung, by Region, 2019-2027 (USD Million)
Table 51. Global Mesenchymal Stem Cells Market Size, by Peripheral Blood, 2019-2027 (USD Million)
Table 52. Global Mesenchymal Stem Cells Market Size, by Peripheral Blood, by Region, 2019-2027 (USD Million)
Table 53. Global Mesenchymal Stem Cells Market Size, by Peripheral Blood, by Region, 2019-2027 (USD Million)
Table 54. Global Mesenchymal Stem Cells Market Size, by Application, 2019-2027 (USD Million)
Table 55. Global Mesenchymal Stem Cells Market Size, by Disease Modeling, 2019-2027 (USD Million)
Table 56. Global Mesenchymal Stem Cells Market Size, by Disease Modeling, by Region, 2019-2027 (USD Million)
Table 57. Global Mesenchymal Stem Cells Market Size, by Disease Modeling, by Region, 2019-2027 (USD Million)
Table 58. Global Mesenchymal Stem Cells Market Size, by Drug Development & Discovery, 2019-2027 (USD Million)
Table 59. Global Mesenchymal Stem Cells Market Size, by Drug Development & Discovery, by Region, 2019-2027 (USD Million)
Table 60. Global Mesenchymal Stem Cells Market Size, by Drug Development & Discovery, by Region, 2019-2027 (USD Million)
Table 61. Global Mesenchymal Stem Cells Market Size, by Stem Cell Banking, 2019-2027 (USD Million)
Table 62. Global Mesenchymal Stem Cells Market Size, by Stem Cell Banking, by Region, 2019-2027 (USD Million)
Table 63. Global Mesenchymal Stem Cells Market Size, by Stem Cell Banking, by Region, 2019-2027 (USD Million)
Table 64. Global Mesenchymal Stem Cells Market Size, by Tissue Engineering, 2019-2027 (USD Million)
Table 65. Global Mesenchymal Stem Cells Market Size, by Tissue Engineering, by Region, 2019-2027 (USD Million)
Table 66. Global Mesenchymal Stem Cells Market Size, by Tissue Engineering, by Region, 2019-2027 (USD Million)
Table 67. Global Mesenchymal Stem Cells Market Size, by Toxicology Studies, 2019-2027 (USD Million)
Table 68. Global Mesenchymal Stem Cells Market Size, by Toxicology Studies, by Region, 2019-2027 (USD Million)
Table 69. Global Mesenchymal Stem Cells Market Size, by Toxicology Studies, by Region, 2019-2027 (USD Million)
Table 70. Global Mesenchymal Stem Cells Market: License & Pricing

Companies Mentioned

  • Astellas Pharma Inc.
  • Axol Biosciences Ltd.
  • BrainStorm Cell Therapeutics Inc.
  • Cell Applications, Inc.
  • Celprogen, Inc.
  • Cyagen Biosciences, Inc.
  • Genlantis, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Mesoblast Limited
  • Neuromics
  • Pluristem Therapeutics Inc.
  • PromoCell GmbH
  • R&D Systems, Inc.
  • ScienCell Research Laboratories, Inc.
  • Smith & Nephew PLC
  • Stemcell Technologies Inc.
  • Stemedica Cell Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Vericel Corporation

Methodology

Loading
LOADING...